IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients.

Zhang, Q

IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients. [electronic resource] - Journal of viral hepatitis Jul 2014 - 525-32 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1365-2893

10.1111/jvh.12177 doi


Adult
Aged
DNA, Viral--blood
Female
Follow-Up Studies
Genotype
Hepatitis B e Antigens--blood
Hepatitis B virus--classification
Hepatitis B, Chronic--drug therapy
Humans
Interferon-alpha--therapeutic use
Interferons
Interleukins--genetics
Male
Middle Aged
Polymorphism, Single Nucleotide
Prognosis
Treatment Outcome
Viral Load
Young Adult